OnKure Therapeutics, Inc.
OKUR
$2.60
-$0.02-0.76%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.70M | -15.39M | -15.93M | -17.44M | -11.56M |
| Total Depreciation and Amortization | 204.00K | 212.00K | 212.00K | 208.00K | 155.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | 14.00K | 127.00K |
| Total Other Non-Cash Items | 2.96M | 2.91M | 2.75M | 2.71M | 77.00K |
| Change in Net Operating Assets | -1.51M | -1.00M | -1.04M | -8.84M | 536.00K |
| Cash from Operations | -13.04M | -13.27M | -14.01M | -23.35M | -10.66M |
| Capital Expenditure | -6.00K | -13.00K | -18.00K | -15.00K | -18.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 15.93M | -- |
| Cash from Investing | -6.00K | -13.00K | -18.00K | 15.91M | -18.00K |
| Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 58.88M | 5.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -77.00K | 51.36M | 0.00 |
| Cash from Financing | 0.00 | 0.00 | -77.00K | 110.25M | 5.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.04M | -13.29M | -14.10M | 102.80M | -10.67M |